c19early.org
COVID-19 Treatment Clinical Evidence
COVID-19 involves the interplay of 500+ viral and host proteins and factors, providing many therapeutic targets.
c19early analyzes 6,000+ studies for 220+ treatments—over 17 million hours of research.
Only three high-profit early treatments are approved in the US.
In reality, many treatments reduce risk,
with 26 low-cost treatments approved across 163 countries.
-
Naso/
oropharyngeal treatment Effective Treatment directly to the primary source of initial infection. -
Healthy lifestyles Protective Exercise, sunlight, a healthy diet, and good sleep all reduce risk.
-
Immune support Effective Vitamins A, C, D, and zinc show reduced risk, as with other viruses.
-
Thermotherapy Effective Methods for increasing internal body temperature, enhancing immune system function.
-
Systemic agents Effective Many systemic agents reduce risk, and may be required when infection progresses.
-
High-profit systemic agents Conditional Effective, but with greater access and cost barriers.
-
Monoclonal antibodies Limited Utility Effective but rarely used—high cost, variant dependence, IV/SC admin.
-
Acetaminophen Harmful Increased risk of severe outcomes and mortality.
-
Remdesivir Harmful Increased mortality with longer followup. Increased kidney and liver injury, cardiac disorders.
,
Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial,
Journal of Medical Virology,
doi:10.1002/jmv.26636
,
Effect of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: Preliminary Results,
SN Comprehensive Clinical Medicine,
doi:10.1007/s42399-020-00374-1
,
Compassionate Use of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: a Case-Control Study,
SN Comprehensive Clinical Medicine,
doi:10.1007/s42399-021-00849-9
,
Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study,
International Immunopharmacology,
doi:10.1016/j.intimp.2020.107261
,
A Plausible "Penny" Costing Effective Treatment for Corona Virus - Ozone Therapy,
Journal of Infectious Diseases and Epidemiology,
doi:10.23937/2474-3658/1510113
,
Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience,
Medical Gas Research,
doi:10.4103/2045-9912.273962
,
Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study),
International Immunopharmacology,
doi:10.1016/j.intimp.2020.107301
,
CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial,
International Immunopharmacology,
doi:10.1016/j.intimp.2021.107874